Capricor Therapeutics (CAPR) Total Debt (2010 - 2024)

Capricor Therapeutics' Total Debt history runs 15 years deep, the most recent figure standing at $3.4 million for Q3 2024.

• In Q3 2024, Total Debt changed 0.0% year-over-year to $3.4 million; the TTM figure through Sep 2024 stood at $3.4 million (changed 0.0% YoY), while the FY2023 annual figure was $3.4 million, down 2.57% from the prior year.
• Total Debt for Q3 2024 stood at $3.4 million, roughly flat from $3.4 million in the prior quarter.
• The five-year high for Total Debt was $4.0 million in Q4 2021, with the low at $35469.0 in Q1 2021.
• The 5-year median for Total Debt is $3.4 million (2020), against an average of $2.9 million.
• The sharpest annual moves came in 2021 and 2022: Total Debt tumbled 98.95% in 2021, then soared 11039.61% in 2022.
• Capricor Therapeutics' Total Debt stood at $71471.0 in 2020, then surged by 5462.6% to $4.0 million in 2021, then slipped by 12.83% to $3.5 million in 2022, then decreased by 2.57% to $3.4 million in 2023, then changed by 0.0% to $3.4 million in 2024.
• Business Quant data shows CAPR's Total Debt at $3.4 million in Q3 2024, $3.4 million in Q2 2024, and $3.4 million in Q1 2024.